NXNL1 Polyclonal Antibody

Background:
Retinitis pigmentosa (RP) is a disease that leads to blindness by degeneration of cone photoreceptors. Rods produce factors required for cone viability. The protein encoded by this gene is one of those factors and is similar to a truncated form of thioredoxin. This gene has been proposed to have therapeutic value against RP.

Research Area: Cell Biology, Metabolism

Synonyms:
Nucleoredoxin like 1, Nucleoredoxin-like protein 1, Nxnl1, NXNL1, RDCVF, Rod derived cone viability factor, Thioredoxin like 6, Thioredoxin-like protein 6

Immunogen: Fusion protein of human NXNL1

Swissprot: Q96CM4
Gene Accession: BC014127

Purification Method: Antigen affinity purification

Buffer: PBS with 0.05% NaN3 and 40% Glycerol, pH7.4

Concentration: 0.78 mg/mL
Dilution: IHC 1:30-1:150, ELISA 1:5000-1:10000

Storage:
Store at -20°C. Avoid freeze / thaw cycles.